PRAXIS PRECISION MEDICINES, INC. (PRAX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in CapitalUSD $2.66B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.67M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in CapitalUSD $2.64B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.59M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in CapitalUSD $2.02B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $563.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $1.39B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $500.00K.
PRAXIS PRECISION MEDICINES, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $15.00K | $2.66B | $-2.67M | $-1.32B | $1.34B | 0.00 | 3 month · $11.31M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $15.00K | $2.64B | $-1.59M | $-1.23B | $1.41B | 0.00 | 3 month · $17.11M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $15.00K | $2.02B | $563.00K | $-1.14B | $878.14M | 0.00 | 12 month · $33.94M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $14.00K | $1.39B | $500.00K | $-1.05B | $343.50M | 0.00 | 3 month · $7.45M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $14.00K | $1.38B | $395.00K | $-977.16M | $404.22M | 0.00 | 3 month · $7.77M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $14.00K | $1.34B | $659.00K | $-906.04M | $439.21M | 0.00 | 3 month · $8.79M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $14.00K | $1.28B | $654.00K | $-836.74M | $445.45M | 0.00 | 3 month · $8.57M 12 month · $41.36M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $14.00K | $1.16B | $1.33M | $-778.06M | $382.67M | 0.00 | 3 month · $12.43M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $14.00K | $1.15B | $-71.00K | $-726.15M | $419.10M | 0.00 | 3 month · $5.88M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $13.00K | $923.14M | $3.00K | $-693.47M | $229.68M | 0.00 | 3 month · $14.47M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $13.00K | $723.58M | $0.00 | $-653.92M | $69.67M | 0.00 | 3 month · $5.73M 12 month · $24.86M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $13.00K | $713.79M | $0.00 | $-627.04M | $86.76M | 0.00 | 3 month · $5.76M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $13.00K | $708.02M | $0.00 | $-602.41M | $105.62M | 0.00 | 3 month · $5.78M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $6.00K | $632.58M | $-19.00K | $-568.10M | $64.47M | 0.00 | 3 month · $7.59M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $5.00K | $606.92M | $-173.00K | $-530.64M | $76.11M | 0.00 | 3 month · $6.37M | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $5.00K | $595.16M | $-536.00K | $-489.47M | $105.16M | 0.00 | 3 month · $6.73M | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $5.00K | $585.07M | $-680.00K | $-445.53M | $138.87M | (m) | 3 month · $7.61M | (m) | (m) | 0.00 |
| 2022-03-31 | $0.00 | $5.00K | $576.96M | $-606.00K | $-385.33M | $191.02M | (m) | 3 month · $7.89M | (m) | (m) | 0.00 |
| 2021-12-31 | $0.00 | $5.00K | $567.60M | $-176.00K | $-316.62M | $250.81M | 0.00 | 3 month · $6.11M | (m) | (m) | 0.00 |
| 2021-09-30 | $0.00 | $5.00K | $553.98M | $-25.00K | $-258.03M | $295.92M | (m) | 3 month · $6.52M | (m) | (m) | 0.00 |
| 2021-06-30 | $0.00 | $5.00K | $547.14M | $-50.00K | $-213.33M | $333.77M | (m) | 3 month · $5.40M 6 month · $10.07M | 3 month · $229.00K 6 month · $229.00K | (m) | 0.00 |
| 2021-03-31 | $0.00 | $4.00K | $442.52M | $-86.00K | $-176.93M | $265.51M | (m) | 3 month · $4.67M | (m) | (m) | 0.00 |
| 2020-12-31 | $0.00 | $4.00K | $437.01M | $0.00 | $-149.55M | $287.46M | (m) | 3 month · $3.83M 12 month · $5.21M | (m) | 3 month · $950.00K 12 month · $9.00M | 0.00 |
| 2020-09-30 | (m) | $1.00K | (m) | (m) | $-123.26M | $-123.26M | (m) | 3 month · $953.00K 9 month · $1.39M | (m) | 3 month · $3.94M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-104.08M | (m) | 3 month · $285.00K 6 month · $432.00K | (m) | 3 month · $2.04M 6 month · $4.10M | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-90.76M | (m) | 3 month · $147.00K | (m) | 3 month · $2.06M | (m) |
| 2019-12-31 | $0.00 | $1.00K | $0.00 | (m) | $-81.01M | $-81.01M | (m) | 12 month · $668.00K | (m) | 12 month · $5.13M | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-72.06M | (m) | 3 month · $276.00K 9 month · $510.00K | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-60.46M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-41.04M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |